State Street’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147M | Buy |
2,745,564
+250,821
| +10% | +$13.4M | 0.01% | 1094 |
|
|
2025
Q1 | $101M | Buy |
2,494,743
+158,799
| +7% | +$6.43M | ﹤0.01% | 1262 |
|
|
2024
Q4 | $65M | Sell |
2,335,944
-167,002
| -7% | -$4.65M | ﹤0.01% | 1588 |
|
|
2024
Q3 | $71.8M | Sell |
2,502,946
-186,480
| -7% | -$5.35M | ﹤0.01% | 1515 |
|
|
2024
Q2 | $63.1M | Sell |
2,689,426
-1,108,304
| -29% | -$26M | ﹤0.01% | 1541 |
|
|
2024
Q1 | $95.9M | Sell |
3,797,730
-1,325,165
| -26% | -$33.5M | ﹤0.01% | 1333 |
|
|
2023
Q4 | $120M | Buy |
5,122,895
+2,617,047
| +104% | +$61.1M | 0.01% | 1173 |
|
|
2023
Q3 | $127M | Buy |
2,505,848
+265,617
| +12% | +$13.4M | 0.01% | 1034 |
|
|
2023
Q2 | $105M | Buy |
2,240,231
+9,424
| +0.4% | +$440K | 0.01% | 1183 |
|
|
2023
Q1 | $85.4M | Sell |
2,230,807
-270,162
| -11% | -$10.3M | ﹤0.01% | 1292 |
|
|
2022
Q4 | $137M | Buy |
2,500,969
+1,953,347
| +357% | +$107M | 0.01% | 966 |
|
|
2022
Q3 | $18.6M | Buy |
547,622
+54,770
| +11% | +$1.86M | ﹤0.01% | 2283 |
|
|
2022
Q2 | $4.66M | Sell |
492,852
-746,265
| -60% | -$7.05M | ﹤0.01% | 3136 |
|
|
2022
Q1 | $17.6M | Buy |
1,239,117
+206,496
| +20% | +$2.93M | ﹤0.01% | 2497 |
|
|
2021
Q4 | $21.8M | Sell |
1,032,621
-121,480
| -11% | -$2.57M | ﹤0.01% | 2420 |
|
|
2021
Q3 | $25.8M | Sell |
1,154,101
-75,039
| -6% | -$1.68M | ﹤0.01% | 2294 |
|
|
2021
Q2 | $30.5M | Buy |
1,229,140
+289,094
| +31% | +$7.17M | ﹤0.01% | 2212 |
|
|
2021
Q1 | $27.3M | Buy |
940,046
+112,162
| +14% | +$3.25M | ﹤0.01% | 2155 |
|
|
2020
Q4 | $21.4M | Buy |
827,884
+610,271
| +280% | +$15.7M | ﹤0.01% | 2209 |
|
|
2020
Q3 | $6.7M | Buy |
217,613
+30,023
| +16% | +$924K | ﹤0.01% | 2650 |
|
|
2020
Q2 | $4.68M | Buy |
187,590
+68,806
| +58% | +$1.71M | ﹤0.01% | 2793 |
|
|
2020
Q1 | $2.52M | Buy |
118,784
+30,770
| +35% | +$652K | ﹤0.01% | 2955 |
|
|
2019
Q4 | $1.95M | Buy |
88,014
+18,560
| +27% | +$412K | ﹤0.01% | 3260 |
|
|
2019
Q3 | $1.58M | Buy |
+69,454
| New | +$1.58M | ﹤0.01% | 3291 |
|